Lawmakers slam slow progress on UK drug pricing overhaul

LONDON Wed Jan 16, 2013 1:09pm IST

Related Topics

A statue of Ganesh, the deity of prosperity, is carried in a taxi to a place of worship on the first day of the ten-day-long Ganesh Chaturthi festival in Mumbai August 29, 2014. REUTERS/Danish Siddiqui

Ganesh Chaturthi Festival

During Ganesh Chaturthi idols will be taken through the streets in a procession accompanied by dancing and singing, and will be immersed in a river or the sea in accordance with Hindu faith.  Slideshow 

LONDON (Reuters) - British lawmakers have criticized the government's failure to detail a new system for medicines pricing that is due to be introduced next January, saying lack of clarity is creating uncertainty for industry and doctors.

The House of Commons Health Committee called on the government on Wednesday to make clear its plans by the end of March 2013.

"There has been extensive discussion of the principle of value-based pricing but it remains a source of concern that so little progress has been made on defining this nebulous concept," the committee said in a report.

The government announced in 2010 that it planned an overhaul medicine pricing from 2014 by adopting a new system of "value-based pricing" - a concept that has so far not been clearly defined.

Drug prices are under growing pressure across Europe as governments tackle ballooning budget deficits, and firms fear the British changes might lead to direct price controls or further obstacles to launching new therapies.

"We do not regard it as acceptable that the arrangements for value-based pricing have still not been settled and that those who will have to work with those arrangements are still unclear about what value-based pricing will mean in practice," the committee said.

"Industry needs certainty about how it should bring its products to the NHS (National Health Service), and patient groups and clinicians need to understand what their role will be and how they can make their views heard."

(Reporting by Ben Hirschler; Editing by Hans-Juergen Peters)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Ebola Outbreak

HEALTH SHOWCASE

E-cigarettes

E-cigarettes

WHO urges stiff regulatory curbs on e-cigarettes.  Full Article 

Weighty Issues

Weighty Issues

More parents think their overweight child is 'about right'.  Full Article 

Cancer Drug

Cancer Drug

Pfizer to test Xalkori lung cancer drug with Merck immunotherapy.  Full Article 

Mental Health

Mental Health

Obama tells veterans better mental health care on the way.  Full Article 

Food Regulation

Food Regulation

Russian food safety regulator shuts fifth McDonald's restaurant.  Full Article 

Heinz Recall

Heinz Recall

Heinz recall brings food tracking issue to the fore in China.  Full Article 

Delaying Start

Delaying Start

Delay morning school start for teens: pediatricians.  Full Article 

Birth Control

Birth Control

U.S. moves to ensure birth control access at religious companies.  Full Article